The lifetime risk of heart failure in the U.S. has climbed to 24% — about 1 in 4 people, according to the Heart Failure Society of America’s “HF Stats 2025: Heart Failure Epidemiology and Outcomes Statistics” report. Moreover, estimates project U.S. heart failure expenses could grow from $32 billion in 2020 to as much as $142 billion by 2050.
Currently, 6.7 million Americans live with the condition, a number expected to grow to 8.7 million by 2030. Heart failure contributed to more than 425,000 deaths in 2022 and accounted for nearly half of all cardiovascular deaths, according to a Sept. 22 system news release.
The report highlights major disparities, noting Black Americans experience the highest incidence and mortality rates. It also noted that fewer than 1 in 4 eligible patients with reduced ejection fraction are receiving full guideline-directed therapy — a gap that, if closed, could save an estimated 1.19 million lives annually worldwide.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
